FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Developed in consultation with clinicians and patients for an enhanced user experience
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
Potential of Ayurveda’s contribution in global health system through various innovative practices
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The company will also share results in two additional posters for deuruxolitinib
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Subscribe To Our Newsletter & Stay Updated